First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 26.55 USD 1.45% Market Closed
Updated: Apr 27, 2024

Arcturus Therapeutics Holdings Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcturus Therapeutics Holdings Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Revenue
$166.8m
CAGR 3-Years
160%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Arcturus Therapeutics Holdings Inc
Revenue Breakdown

Breakdown by Geography
Arcturus Therapeutics Holdings Inc

Not Available

Breakdown by Segments
Arcturus Therapeutics Holdings Inc

Total Revenue: 166.8m USD
100%
Collaboration Revenue: 157.7m USD
94.6%

See Also

What is Arcturus Therapeutics Holdings Inc's Revenue?
Revenue
166.8m USD

Based on the financial report for Dec 31, 2023, Arcturus Therapeutics Holdings Inc's Revenue amounts to 166.8m USD.

What is Arcturus Therapeutics Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
60%

Over the last year, the Revenue growth was -19%. The average annual Revenue growth rates for Arcturus Therapeutics Holdings Inc have been 160% over the past three years , 60% over the past five years .